Defining the Regulatory Pathway for a Novel 3D Imaging Technology
Guiding a Pioneering Technology Through FDA Strategy and Clinical Alignment A medical device innovator developing a novel, ultrasound-based technology to evaluate organ tissue characteristics approached AlvaMed with a critical challenge: defining a viable FDA regulatory pathway for a device with no clear predicate and a complex clinical strategy with trials already underway in advance of […]
